Evaluation of arterial stiffness in patients with coronary atherosclerosis, cardiac syndrome X and systemic lupus erythematosus (RCD code: I-3C.1)
Journal Title: Journal of Rare Cardiovascular Diseases - Year 2015, Vol 2, Issue 2
Abstract
Objectives: Arterial stiffness manifested by high pulse wave velocity (PWV) consists a risk factor of atherosclerosis and cardio-vascular complications. Systemic lupus erythematosus (SLE) is a generalized autoimmune disease in which patients’ prognosis depends contemporarily, in the corticosteroid era, mainly on the progression of premature atherosclerosis. The aim of the study was to assess arterial stiffness in patients with coronary atherosclerosis (CA), cardiac syndrome X (CSX) and SLE.Materials and methods: 44 CSX patients (28 females and 16 males; mean age 55,7; arterial hypertension in 32), 44 CA patients (19 females and 25 males; mean age 61,3; arterial hypertension in 41), 29 SLE patients (25 females and 4 males; mean age 37,4; arterial hypertension in 7), 29 control group (CG) patients. PWV was measured with use of SphygmoCor in all patients.Results: Patients with CSX had significantly lower PWV (9,63±1,69 m/s) as compared to CA patients (11,53±2,19 m/s) and significantly higher as compared to CG (8,07±1,03m/s) patients. The results of PWV in CSX and SLE patients (8,87±2,1 m/s) were similar. PWV increased with age and blood pressure in all groups. Diabetes mellitus and smoking caused PWV increase only in CA patients. Inflammatory markers didn’t influence PWV among patients with CA, CSX and SLE.Conclusions: Patients with CA have the highest arterial stiffness and significantly higher peripheral and central blood pressure. In SLE patients arterial stiffness is higher as compared to control group and similar as compared to the older CSX group. Diabetes mellitus and smoking increase arterial stiffness among CA patients. The prognostic value of PWV decrease in SLE patients should be addressed in large prospective clinical trials. JRCD 2015; 2 (2): 9–17
Authors and Affiliations
Hanna Dziedzic-Oleksy, Barbara Widlińska, Jakub Stępniewski, Agnieszka Sarnecka, Klaudia Knap, Grzegorz Kopeć, Wojciech Płazak, Piotr Podolec
Keywords
Related Articles
- EP ID EP245455
- DOI 10.20418/jrcd.vol2no2.173
- Views 102
- Downloads 0
Rare diseases and disorders and rare cardiovascular complications
n/a
Heart affected by amyloidosis – a case study (RCD code: III-3A.2)
We present a case of a 65-year old woman, who was admitted to hospital due to recurrent pulmonary oedema. Patient's history included chronic obstructive pulmonary disease. Echocardiography revealed a concentric hypertrop...
Combination therapy in the treatment of pulmonary arterial hypertension - 2015 update.
Pulmonary arterial hypertension (PAH) is a disease with a poor prognosis and high mortality rates therefore in the era of advanced therapies targeting different patophysiological pathways attractive seems the idea of com...
Journal of Rare Cardiovascular Diseases: “Conquering new territories” – a new educational program on rare diseases for medical acolytes
Dear Readers,Nowadays, we witness dramatic changes in the perception of rare diseases. Thanks to the European Union(EU) regulations but more importantly due to increasing pressure from the spontaneous patients’ organiza...
Ruptured aneurysm of sinus of Valsalva – an unexpected cause of tachycardia and severe dyspnea in a young patient (RCD code: I‑1B.0)
The presented case report illustrates a rare and unexpected cause of tachycardia and exercise tolerance reduction in a young patient with noncoronary sinus of Valsalva aneurysm rupture. The patient was referred to our ho...